Speed Medical SAE

Speed Medical SAE has a liquidity ratio of 0.61, indicating that its current assets are less than its current liabilities, which suggests a potential liquidity risk. The company's debt-to-equity ratio is 0.7, which is relatively low, but the negative net cash position after subtracting total debt raises concerns about its short-term financial stability. The company's profitability is negative, with a return on equity of -3.92% and a return on assets of -1.9%, which are below the industry norms for a healthcare services and equipment provider. These figures indicate that the company is not generating sufficient returns to cover its costs and is not performing well compared to its peers. Speed Medical SAE's revenue is concentrated in a single geographic region, primarily Egypt, which increases its exposure to local economic and political risks. The company does not disclose segment-specific revenue, making it difficult to assess the performance of different parts of its business. The company's growth trajectory is uncertain, as it has reported negative operating and net income. The outlook for the current fiscal year does not indicate a significant improvement in revenue or profitability. The company's capital expenditure is negative, suggesting a reduction in investment in new projects or assets. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, suggesting that it may need to raise additional capital or restructure its debt to maintain operations. Recent events, such as the company's financial performance and capital structure, suggest that it is facing challenges in maintaining profitability and liquidity. The company's financial statements and disclosures do not indicate any major recent events that would significantly impact its operations or financial position.